Alternative Gene Networks Restore Neural Circuits

Researchers at the Fralin Biomedical Research Institute have identified a new path for treating genetic brain disorders. The study focused on 22q11.2 deletion syndrome, a condition associated with schizophrenia and autism. Rather than attempting the difficult task of repairing the missing genetic material, the team targeted the cellular damage caused by the deletion.

The researchers used a mouse model to show that mitochondrial oxidative stress drives abnormal neuron development. By administering N-acetyl cysteine, an antioxidant capable of crossing the blood-brain barrier, they reduced this oxidative burden. The treatment improved mitochondrial health and allowed neurons to form functional connections.

Crucially, the therapy did not restore the original gene expression levels. Instead, the intervention triggered an alternative network of compensatory genes. This adjustment enabled the brain to build functional circuits despite the underlying genetic gap. The mice treated with the antioxidant showed measurable improvements in learning and cognitive flexibility during behavioral testing.

This approach signals a shift in neurodevelopmental research. While traditional methods focus on correcting mutations, this evidence suggests that engaging the inherent flexibility of gene networks can produce therapeutic results. These findings provide a blueprint for addressing other microdeletion syndromes where direct gene editing remains a clinical challenge.